DarshanTalks Podcast
Summary: Regulatory guy. Irregular podcast.
- Visit Website
- RSS
- Artist: Darshan Kulkarni
- Copyright: All rights reserved
Podcasts:
Website: http://www.Darshantalks.com Law Firm: http://www.kulkarnilawfirm.com Sign up for my newsletter: http://recentrecap.darshankulkarni.com/ Twitter: https://twitter.com/darshantalks LinkedIn: https://www.linkedin.com/in/darshankulkarni/ Google Play: https://play.google.com/music/m/Ioklyrkupu6g2iswf5eiim46afe?t=DarshanTalks_Podcast ---- Disclaimers: 1. This discussion is merely an oral discussion and should not be relied upon solely on its own to support any conclusion of law or fact. 2. The discussion does not and should not reflect any individual products status as safe, efficacious, adulterated or misbranded or meeting or not meeting expectations at a local, state, federal, or international agency or organization. 3. The discussion should not be construed to be complete advice that is right for you and may not necessarily represent a specific product. 4. This discussion is provided for general educational purposes and should not be construed as legal advice, regulatory advice or medical advice. 5. This does not create an attorney-client relationship
Website: http://www.Darshantalks.com Law Firm: http://www.kulkarnilawfirm.com Sign up for my newsletter: http://recentrecap.darshankulkarni.com/ Twitter: https://twitter.com/darshantalks LinkedIn: https://www.linkedin.com/in/darshankulkarni/ Google Play: https://play.google.com/music/m/Ioklyrkupu6g2iswf5eiim46afe?t=DarshanTalks_Podcast ---- Disclaimers: 1. This discussion is merely an oral discussion and should not be relied upon solely on its own to support any conclusion of law or fact. 2. The discussion does not and should not reflect any individual products status as safe, efficacious, adulterated or misbranded or meeting or not meeting expectations at a local, state, federal, or international agency or organization. 3. The discussion should not be construed to be complete advice that is right for you and may not necessarily represent a specific product. 4. This discussion is provided for general educational purposes and should not be construed as legal advice, regulatory advice or medical advice. 5. This does not create an attorney-client relationship
Website: http://www.Darshantalks.com Law Firm: http://www.kulkarnilawfirm.com Sign up for my newsletter: http://recentrecap.darshankulkarni.com/ Twitter: https://twitter.com/darshantalks LinkedIn: https://www.linkedin.com/in/darshankulkarni/ Google Play: https://play.google.com/music/m/Ioklyrkupu6g2iswf5eiim46afe?t=DarshanTalks_Podcast ---- Disclaimers: 1. This discussion is merely an oral discussion and should not be relied upon solely on its own to support any conclusion of law or fact. 2. The discussion does not and should not reflect any individual products status as safe, efficacious, adulterated or misbranded or meeting or not meeting expectations at a local, state, federal, or international agency or organization. 3. The discussion should not be construed to be complete advice that is right for you and may not necessarily represent a specific product. 4. This discussion is provided for general educational purposes and should not be construed as legal advice, regulatory advice or medical advice. 5. This does not create an attorney-client relationship
Insys admits to orchestrating a nationwide sham "speaker program" and Mallinckrodt raises drug price by over 100,000% (not a typo) and bribes docs to prescribe. Website: www.Darshantalks.com Law Firm: www.kulkarnilawfirm.com Sign up for my newsletter: http://recentrecap.darshankulkarni.com/ Twitter: twitter.com/darshantalks LinkedIn: www.linkedin.com/in/darshankulkarni/ Google Play: play.google.com/music/m/Ioklyrkup…shanTalks_Podcast ---- Disclaimers: 1. This discussion is merely an oral discussion and should not be relied upon solely on its own to support any conclusion of law or fact. 2. The discussion does not and should not reflect any individual products status as safe, efficacious, adulterated or misbranded or meeting or not meeting expectations at a local, state, federal, or international agency or organization. 3. The discussion should not be construed to be complete advice that is right for you and may not necessarily represent a specific product. 4. This discussion is provided for general educational purposes and should not be construed as legal advice, regulatory advice or medical advice. 5. This does not create an attorney-client relationship
Website: http://www.Darshantalks.com Law Firm: http://www.kulkarnilawfirm.com Sign up for my newsletter: http://recentrecap.darshankulkarni.com/ Twitter: https://twitter.com/darshantalks LinkedIn: https://www.linkedin.com/in/darshankulkarni/ Google Play: https://play.google.com/music/m/Ioklyrkupu6g2iswf5eiim46afe?t=DarshanTalks_Podcast ---- Disclaimers: 1. This discussion is merely an oral discussion and should not be relied upon solely on its own to support any conclusion of law or fact. 2. The discussion does not and should not reflect any individual products status as safe, efficacious, adulterated or misbranded or meeting or not meeting expectations at a local, state, federal, or international agency or organization. 3. The discussion should not be construed to be complete advice that is right for you and may not necessarily represent a specific product. 4. This discussion is provided for general educational purposes and should not be construed as legal advice, regulatory advice or medical advice. 5. This does not create an attorney-client relationship
Prescriptive rights and utilitarianism as it applies to bioethical decision making Website: http://www.Darshantalks.com Law Firm: http://www.kulkarnilawfirm.com Sign up for my newsletter: http://recentrecap.darshankulkarni.com/ Twitter: https://twitter.com/darshantalks LinkedIn: https://www.linkedin.com/in/darshankulkarni/ Google Play: https://play.google.com/music/m/Ioklyrkupu6g2iswf5eiim46afe?t=DarshanTalks_Podcast ---- Disclaimers: 1. This discussion is merely an oral discussion and should not be relied upon solely on its own to support any conclusion of law or fact. 2. The discussion does not and should not reflect any individual products status as safe, efficacious, adulterated or misbranded or meeting or not meeting expectations at a local, state, federal, or international agency or organization. 3. The discussion should not be construed to be complete advice that is right for you and may not necessarily represent a specific product. 4. This discussion is provided for general educational purposes and should not be construed as legal advice, regulatory advice or medical advice. 5. This does not create an attorney-client relationship
Website: http://www.Darshantalks.com Law Firm: http://www.kulkarnilawfirm.com Sign up for my newsletter: http://recentrecap.darshankulkarni.com/ Twitter: https://twitter.com/darshantalks LinkedIn: https://www.linkedin.com/in/darshankulkarni/ Google Play: https://play.google.com/music/m/Ioklyrkupu6g2iswf5eiim46afe?t=DarshanTalks_Podcast ---- Disclaimers: 1. This discussion is merely an oral discussion and should not be relied upon solely on its own to support any conclusion of law or fact. 2. The discussion does not and should not reflect any individual products status as safe, efficacious, adulterated or misbranded or meeting or not meeting expectations at a local, state, federal, or international agency or organization. 3. The discussion should not be construed to be complete advice that is right for you and may not necessarily represent a specific product. 4. This discussion is provided for general educational purposes and should not be construed as legal advice, regulatory advice or medical advice. 5. This does not create an attorney-client relationship
23 and me sold your data to Glaxo Smith Kline ( GSK ) for $500 million. Is this ethically justified? Website: http://www.Darshantalks.com Law Firm: http://www.kulkarnilawfirm.com Sign up for my newsletter: http://recentrecap.darshankulkarni.com/ Twitter: https://twitter.com/darshantalks LinkedIn: https://www.linkedin.com/in/darshankulkarni/ Google Play: https://play.google.com/music/listen?u=0#/ps/Ioklyrkupu6g2iswf5eiim46afe
Website: http://www.Darshantalks.com Law Firm: http://www.kulkarnilawfirm.com Sign up for my newsletter: http://recentrecap.darshankulkarni.com/ Twitter: https://twitter.com/darshantalks LinkedIn: https://www.linkedin.com/in/darshankulkarni/ Google Play: https://play.google.com/music/m/Ioklyrkupu6g2iswf5eiim46afe?t=DarshanTalks_Podcast ---- Disclaimers: 1. This discussion is merely an oral discussion and should not be relied upon solely on its own to support any conclusion of law or fact. 2. The discussion does not and should not reflect any individual products status as safe, efficacious, adulterated or misbranded or meeting or not meeting expectations at a local, state, federal, or international agency or organization. 3. The discussion should not be construed to be complete advice that is right for you and may not necessarily represent a specific product. 4. This discussion is provided for general educational purposes and should not be construed as legal advice, regulatory advice or medical advice. 5. This does not create an attorney-client relationship
E-cig companies are traversing the wild west of regulations... Check out my weekly curated content here: http://recentrecap.darshankulkarni.com/ Leave a comment and tell me what you think. ---- Disclaimers: 1. This discussion is merely an oral discussion and should not be relied upon solely on its own to support any conclusion of law or fact. 2. The discussion does not and should not reflect any individual products status as safe, efficacious, adulterated or misbranded or meeting or not meeting expectations at a local, state, federal, or international agency or organization. 3. The discussion should not be construed to be complete advice that is right for you and may not necessarily represent a specific product. 4. This discussion is provided for general educational purposes and should not be construed as legal advice, regulatory advice or medical advice. 5. This does not create an attorney-client relationship
Snake oil salesmen still exist, and they're worse than ever. Check out my weekly curated content here: http://recentrecap.darshankulkarni.com/ Leave a comment and tell me what you think.
I've heard Ad Agencies say that an FDA Warning Letter is a badge of honor because it shows that you "push the envelope." ...but is pushing the envelope worth further FDA scrutiny? ---- Disclaimers: 1. This discussion is merely an oral discussion and should not be relied upon solely on its own to support any conclusion of law or fact. 2. The discussion does not and should not reflect any individual products status as safe, efficacious, adulterated or misbranded or meeting or not meeting expectations at a local, state, federal, or international agency or organization. 3. The discussion should not be construed to be complete advice that is right for you and may not necessarily represent a specific product. 4. This discussion is provided for general educational purposes and should not be construed as legal advice, regulatory advice or medical advice. 5. This does not create an attorney-client relationship
During a government shutdown, to what extent are patients considered? Website: http://www.Darshantalks.com Law Firm: http://www.kulkarnilawfirm.com Sign up for my newsletter: http://recentrecap.darshankulkarni.com/ Twitter: https://twitter.com/darshantalks LinkedIn: https://www.linkedin.com/in/darshankulkarni/ Google Play: https://play.google.com/music/m/Ioklyrkupu6g2iswf5eiim46afe?t=DarshanTalks_Podcast ---- Disclaimers: 1. This discussion is merely an oral discussion and should not be relied upon solely on its own to support any conclusion of law or fact. 2. The discussion does not and should not reflect any individual products status as safe, efficacious, adulterated or misbranded or meeting or not meeting expectations at a local, state, federal, or international agency or organization. 3. The discussion should not be construed to be complete advice that is right for you and may not necessarily represent a specific product. 4. This discussion is provided for general educational purposes and should not be construed as legal advice, regulatory advice or medical advice. 5. This does not create an attorney-client relationship
Check out and signup for my newsletter: http://recentrecap.darshankulkarni.com/issues/recent-recap-issue-16-180552 ---- Disclaimers: 1. This discussion is merely an oral discussion and should not be relied upon solely on its own to support any conclusion of law or fact. 2. The discussion does not and should not reflect any individual products status as safe, efficacious, adulterated or misbranded or meeting or not meeting expectations at a local, state, federal, or international agency or organization. 3. The discussion should not be construed to be complete advice that is right for you and may not necessarily represent a specific product. 4. This discussion is provided for general educational purposes and should not be construed as legal advice, regulatory advice or medical advice. 5. This does not create an attorney-client relationship
Clinical Trial enrollment is the first hurdle. Here's how you get participants to stay. Website: http://www.Darshantalks.com Law Firm: http://www.kulkarnilawfirm.com Sign up for my newsletter: http://recentrecap.darshankulkarni.com/ Twitter: https://twitter.com/darshantalks LinkedIn: https://www.linkedin.com/in/darshankulkarni/ Google Play: https://play.google.com/music/m/Ioklyrkupu6g2iswf5eiim46afe?t=DarshanTalks_Podcast ---- Disclaimers: 1. This discussion is merely an oral discussion and should not be relied upon solely on its own to support any conclusion of law or fact. 2. The discussion does not and should not reflect any individual products status as safe, efficacious, adulterated or misbranded or meeting or not meeting expectations at a local, state, federal, or international agency or organization. 3. The discussion should not be construed to be complete advice that is right for you and may not necessarily represent a specific product. 4. This discussion is provided for general educational purposes and should not be construed as legal advice, regulatory advice or medical advice. 5. This does not create an attorney-client relationship